Gilead Sciences, Inc
BMV:GILD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
G
|
Gilead Sciences, Inc
BMV:GILD
|
US |
|
P
|
Paccar Inc
DUS:PAE
|
US |
|
H
|
Hormel Foods Corp
XMUN:HO7
|
US |
|
Zeda Ltd
F:LJ0
|
ZA |
|
Craneware PLC
F:3X6
|
UK |
|
B2 Impact ASA
F:B28
|
NO |
|
P
|
Paccar Inc
F:PAE
|
US |
|
G
|
Gilead Sciences, Inc
F:GIS
|
US |
|
Orion180 Insurance Group Inc.
NASDAQ:OIG
|
US |
Intrinsic Value
Is GILD undervalued or overvalued?
See the intrinsic value estimate for 
Gilead Sciences, Inc and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Gilead Sciences Does
Gilead Sciences is a biopharmaceutical company that develops and sells prescription medicines, especially in antiviral treatments. Its best-known products have been used to treat HIV, hepatitis B and C, and it also sells medicines for cancer and inflammatory diseases. The company focuses on discovering drugs, testing them in clinical trials, getting them approved, and then manufacturing and marketing them to patients who need long-term treatment.
- Headquarters
- United States of America US
- Employees
- 17 000
- IPO date
- Jan 22, 1992
Gilead Sciences has a wide economic moat
Patents keep rivals from copying important Gilead medicines such as Biktarvy, allowing the company to earn profits from treatments competitors cannot freely reproduce. The medical review needed to change a successful HIV treatment also helps protect its established patient base, particularly when drug resistance limits alternatives.
Read the full moat analysis
Revenue & Expenses Breakdown
Gilead Sciences, Inc
Earnings Waterfall
Gilead Sciences, Inc
The intrinsic value for Gilead Sciences, Inc (GILD) under the Base Case is hidden MXN.
Compared with the current market price of 3 188.6001 MXN, the stock appears hidden.
